Opus Genetics, Inc. (IRD) NASDAQ
4.66
-0.14(-2.92%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.66
-0.14(-2.92%)
Currency In USD
| Market Cap | 1.25B |
| Enterprise Value | 1.21B |
| P/E Ratio | -58.47 |
| PEG Ratio | -1.09 |
| Price/Sales Ratio | 22.94 |
| Price/Book Ratio | 188.92 |
| Enterprise/Revenue | 19.77 |
| Enterprise/EBITDA | -6.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -3.49 |
| Operating Margin | -2.72 |
| Return On Assets | -0.99 |
| Return On Equity | -4.52 |
| Revenue | 14.2M |
| Revenue/Share | 0.02 |
| Gross Profit | 14.14M |
| EBITDA | -38.6M |
| Net Income | -49.59M |
| Diluted EPS | -0.8 |
| Total Cash | 45.09M |
| Total Cash/Share | 0.07 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 6.43 |
| Book Value Per Share | 0.02 |
| 52-Week Change | 305.22 |
| 52-Week High | 5.3 |
| 52-Week Low | 0.65 |
| Moving Average 50 Days | 3.32 |
| Moving Average 200 Days | 2 |
| Average Volume | 918,018 |
| Shares Outstanding | 69.89M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | November 06, 2020 |